Drug Profile
LU 36274
Alternative Names: LU 36-274Latest Information Update: 16 Nov 2004
Price :
$50
*
At a glance
- Originator Lundbeck A/S
- Class Antidepressants; Piperazines; Small molecules
- Mechanism of Action 5-HT1A serotonin receptor antagonists; Serotonin uptake inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Major depressive disorder
Most Recent Events
- 16 Nov 2004 Discontinued - Preclinical for Depression in Denmark (unspecified route)
- 16 Mar 2004 Preclinical trials in Depression in Denmark (unspecified route)